US Patent Issued to CASE WESTERN RESERVE UNIVERSITY on Jan. 28 for "Epithelial cancer evaluation using beta defensin" (Ohio Inventors)

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,210,019, issued on Jan. 28, was assigned to CASE WESTERN RESERVE UNIVERSITY (Cleveland).

"Epithelial cancer evaluation using beta defensin" was invented by Aaron Weinberg (Highland Heights, Ohio), Santosh Ghosh (Mayfield Heights, Ohio) and Umut A. Gurkan (Cleveland).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of detecting epithelial cancer is described that includes the steps of: (a) determining the level of beta defensin 3 (BD-3) and beta defensin 2 (BD-2) in a suspect sample obtained from a subject; (b) comparing the level of BD-3 to BD-2 determined in the suspect sample to obtain a suspect BD-3/BD-2 ratio, (c) comparing the suspect BD-3/BD...